Jim Wassil - 17 Apr 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
17 Apr 2024
Net transactions value
+$18,998
Form type
4
Filing time
19 Apr 2024, 16:31:45 UTC
Previous filing
03 Apr 2024
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $18,998 +3,551 +1.6% $5.35* 221,840 17 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -3,551 -4.3% $0.000000 78,611 17 Apr 2024 Common Stock 3,551 $5.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Option is fully vested and exercisable.